

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.10704438 |
| 2 | response to peptidoglycan (GO:0032494) | 4.40726696 |
| 3 | immunoglobulin mediated immune response (GO:0016064) | 4.23157324 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.02705856 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 3.84569031 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 3.84569031 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.84569031 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.84569031 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.84569031 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 3.84569031 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 3.82703452 |
| 12 | detection of bacterium (GO:0016045) | 3.78753297 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.78450009 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.68605107 |
| 15 | detection of other organism (GO:0098543) | 3.65920841 |
| 16 | NIK/NF-kappaB signaling (GO:0038061) | 3.58668819 |
| 17 | response to muramyl dipeptide (GO:0032495) | 3.52356956 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.52180400 |
| 19 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.33677880 |
| 20 | negative regulation of cell killing (GO:0031342) | 3.32099294 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.32099294 |
| 22 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.31071201 |
| 23 | negative regulation of cell size (GO:0045792) | 3.29844997 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 3.28707748 |
| 25 | germinal center formation (GO:0002467) | 3.25172737 |
| 26 | type I interferon signaling pathway (GO:0060337) | 3.19605822 |
| 27 | cellular response to type I interferon (GO:0071357) | 3.19605822 |
| 28 | response to type I interferon (GO:0034340) | 3.17666467 |
| 29 | N-acetylneuraminate metabolic process (GO:0006054) | 3.02561335 |
| 30 | regulation of mast cell degranulation (GO:0043304) | 3.01266902 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.01172732 |
| 32 | B cell mediated immunity (GO:0019724) | 3.00856217 |
| 33 | regulation of necrotic cell death (GO:0010939) | 2.98324956 |
| 34 | negative regulation of necrotic cell death (GO:0060547) | 2.96739768 |
| 35 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.96540314 |
| 36 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.96476308 |
| 37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.96227785 |
| 38 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.95107129 |
| 39 | mannose metabolic process (GO:0006013) | 2.91465697 |
| 40 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.88561120 |
| 41 | response to host immune response (GO:0052572) | 2.87000290 |
| 42 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.87000290 |
| 43 | detection of external biotic stimulus (GO:0098581) | 2.86636635 |
| 44 | modulation by symbiont of host cellular process (GO:0044068) | 2.83684909 |
| 45 | negative regulation of interleukin-12 production (GO:0032695) | 2.83155275 |
| 46 | amino sugar catabolic process (GO:0046348) | 2.81766858 |
| 47 | negative regulation of necroptotic process (GO:0060546) | 2.80329555 |
| 48 | negative regulation of innate immune response (GO:0045824) | 2.77409477 |
| 49 | response to protozoan (GO:0001562) | 2.76440679 |
| 50 | defense response to protozoan (GO:0042832) | 2.76098995 |
| 51 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.75418614 |
| 52 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.74836559 |
| 53 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.74533060 |
| 54 | regulation of antigen processing and presentation (GO:0002577) | 2.73567866 |
| 55 | regulation of necroptotic process (GO:0060544) | 2.73496181 |
| 56 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.72905913 |
| 57 | B cell receptor signaling pathway (GO:0050853) | 2.72646853 |
| 58 | positive thymic T cell selection (GO:0045059) | 2.70535944 |
| 59 | regulation of skeletal muscle contraction (GO:0014819) | 2.70181002 |
| 60 | modulation by virus of host process (GO:0019054) | 2.68731075 |
| 61 | T-helper 1 type immune response (GO:0042088) | 2.67252239 |
| 62 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.65468998 |
| 63 | positive regulation of antigen processing and presentation (GO:0002579) | 2.62568185 |
| 64 | glycosphingolipid catabolic process (GO:0046479) | 2.61656885 |
| 65 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.60987100 |
| 66 | regulation of cholesterol storage (GO:0010885) | 2.60925560 |
| 67 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.60788469 |
| 68 | cellular response to arsenic-containing substance (GO:0071243) | 2.59068275 |
| 69 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.58795417 |
| 70 | creatine metabolic process (GO:0006600) | 2.58782928 |
| 71 | regulation of leukocyte degranulation (GO:0043300) | 2.58336748 |
| 72 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.58034481 |
| 73 | response to host (GO:0075136) | 2.57293808 |
| 74 | response to host defenses (GO:0052200) | 2.57293808 |
| 75 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.57293808 |
| 76 | positive regulation of B cell differentiation (GO:0045579) | 2.57122129 |
| 77 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.56005970 |
| 78 | activation of MAPKKK activity (GO:0000185) | 2.55290128 |
| 79 | adenosine receptor signaling pathway (GO:0001973) | 2.54782393 |
| 80 | pentose-phosphate shunt (GO:0006098) | 2.54397769 |
| 81 | positive regulation of type 2 immune response (GO:0002830) | 2.51354855 |
| 82 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.51013158 |
| 83 | response to thyroid hormone (GO:0097066) | 2.50790090 |
| 84 | myeloid cell activation involved in immune response (GO:0002275) | 2.49865353 |
| 85 | myeloid dendritic cell differentiation (GO:0043011) | 2.49832165 |
| 86 | detection of biotic stimulus (GO:0009595) | 2.49143840 |
| 87 | mature B cell differentiation involved in immune response (GO:0002313) | 2.47925354 |
| 88 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.45988344 |
| 89 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.45695522 |
| 90 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.45265225 |
| 91 | amyloid precursor protein catabolic process (GO:0042987) | 2.43186347 |
| 92 | granulocyte activation (GO:0036230) | 2.42249615 |
| 93 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.41748869 |
| 94 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.41707823 |
| 95 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.40922672 |
| 96 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.40620177 |
| 97 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.39686924 |
| 98 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.39250816 |
| 99 | cellular response to virus (GO:0098586) | 2.36496512 |
| 100 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.35618214 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.43139852 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 2.92326868 |
| 3 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.61127564 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.44089786 |
| 5 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.37461353 |
| 6 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.19870041 |
| 7 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.18648837 |
| 8 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.13723922 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.10644274 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.10459374 |
| 11 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.08097602 |
| 12 | * MAF_26560356_Chip-Seq_TH1_Human | 2.06658527 |
| 13 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.03821351 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.99223706 |
| 15 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.97239701 |
| 16 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.97209901 |
| 17 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.96470625 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.82914009 |
| 19 | MAF_26560356_Chip-Seq_TH2_Human | 1.81782159 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81291842 |
| 21 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.79776602 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 1.78578641 |
| 23 | P68_20966046_ChIP-Seq_HELA_Human | 1.78471946 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.75583496 |
| 25 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.75141920 |
| 26 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.73638825 |
| 27 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.66517429 |
| 28 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.65513718 |
| 29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.65028253 |
| 30 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.63600035 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.62472780 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62284665 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58099819 |
| 34 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.57853081 |
| 35 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.54516293 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53453362 |
| 37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.52196173 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50801884 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.50374756 |
| 40 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.49916981 |
| 41 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.49865922 |
| 42 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.46462348 |
| 43 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.46193398 |
| 44 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.46159480 |
| 45 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.44242395 |
| 46 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.43493831 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43249263 |
| 48 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.41782358 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41417610 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.41180781 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.40252414 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38996768 |
| 53 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.38775406 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.38537634 |
| 55 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38102619 |
| 56 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.37675551 |
| 57 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.34031892 |
| 58 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.33560380 |
| 59 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.32503632 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.30626083 |
| 61 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.30377126 |
| 62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.30319915 |
| 63 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27183699 |
| 64 | KDM2B_26808549_Chip-Seq_K562_Human | 1.25873908 |
| 65 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.24380898 |
| 66 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.23118687 |
| 67 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.21085230 |
| 68 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.19886086 |
| 69 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.19311406 |
| 70 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18694571 |
| 71 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18221797 |
| 72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17959683 |
| 73 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16842303 |
| 74 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.16241527 |
| 75 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16142479 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16055513 |
| 77 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.15997298 |
| 78 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.14957635 |
| 79 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.14614407 |
| 80 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.14407964 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14125161 |
| 82 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.13793557 |
| 83 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.13574704 |
| 84 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.13106023 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12855003 |
| 86 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12833729 |
| 87 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12067933 |
| 88 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.10801301 |
| 89 | SA1_27219007_Chip-Seq_Bcells_Human | 1.10092333 |
| 90 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.09915797 |
| 91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09185095 |
| 92 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.08756348 |
| 93 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07774992 |
| 94 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.07281383 |
| 95 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06562280 |
| 96 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06431311 |
| 97 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06110023 |
| 98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05787807 |
| 99 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04670804 |
| 100 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04436256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.10284839 |
| 2 | MP0005451_abnormal_body_composition | 3.92639348 |
| 3 | MP0009278_abnormal_bone_marrow | 3.61766308 |
| 4 | MP0009840_abnormal_foam_cell | 3.40157239 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.39974943 |
| 6 | MP0003436_decreased_susceptibility_to | 3.12745507 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.51484234 |
| 8 | MP0005397_hematopoietic_system_phenotyp | 2.47917216 |
| 9 | MP0001545_abnormal_hematopoietic_system | 2.47917216 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.44868047 |
| 11 | MP0008260_abnormal_autophagy | 2.34094067 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.31713547 |
| 13 | MP0001790_abnormal_immune_system | 2.29062327 |
| 14 | MP0005387_immune_system_phenotype | 2.29062327 |
| 15 | MP0005025_abnormal_response_to | 2.25967704 |
| 16 | MP0003724_increased_susceptibility_to | 2.21471570 |
| 17 | MP0000685_abnormal_immune_system | 2.16814017 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.14490916 |
| 19 | MP0002419_abnormal_innate_immunity | 2.10224286 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.09167428 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 2.04473025 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.02361600 |
| 23 | MP0009785_altered_susceptibility_to | 2.00606284 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 1.99771520 |
| 25 | MP0001800_abnormal_humoral_immune | 1.98691036 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 1.98200151 |
| 27 | MP0002723_abnormal_immune_serum | 1.90271632 |
| 28 | MP0002452_abnormal_antigen_presenting | 1.88971453 |
| 29 | MP0004510_myositis | 1.79450627 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.77464296 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.76877093 |
| 32 | MP0001819_abnormal_immune_cell | 1.75537904 |
| 33 | MP0005671_abnormal_response_to | 1.70689695 |
| 34 | MP0004947_skin_inflammation | 1.68399042 |
| 35 | MP0002398_abnormal_bone_marrow | 1.60505470 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.58308156 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.52408686 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.51154163 |
| 39 | MP0003646_muscle_fatigue | 1.49239255 |
| 40 | MP0005083_abnormal_biliary_tract | 1.47723576 |
| 41 | MP0000716_abnormal_immune_system | 1.46694550 |
| 42 | MP0000858_altered_metastatic_potential | 1.45699804 |
| 43 | MP0000751_myopathy | 1.44684343 |
| 44 | MP0008004_abnormal_stomach_pH | 1.43069650 |
| 45 | MP0000343_altered_response_to | 1.37773822 |
| 46 | MP0002429_abnormal_blood_cell | 1.35691995 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.34191639 |
| 48 | MP0009764_decreased_sensitivity_to | 1.32950652 |
| 49 | MP0002132_abnormal_respiratory_system | 1.32297648 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.32278739 |
| 51 | MP0000747_muscle_weakness | 1.28517383 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.28378021 |
| 53 | MP0002722_abnormal_immune_system | 1.27745011 |
| 54 | MP0000750_abnormal_muscle_regeneration | 1.26628525 |
| 55 | MP0003453_abnormal_keratinocyte_physiol | 1.26091743 |
| 56 | MP0002139_abnormal_hepatobiliary_system | 1.23292721 |
| 57 | MP0002653_abnormal_ependyma_morphology | 1.22748694 |
| 58 | MP0008469_abnormal_protein_level | 1.22373298 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.21373377 |
| 60 | MP0003075_altered_response_to | 1.18941189 |
| 61 | MP0002405_respiratory_system_inflammati | 1.18647500 |
| 62 | MP0006082_CNS_inflammation | 1.15270794 |
| 63 | MP0000490_abnormal_crypts_of | 1.12474782 |
| 64 | MP0001873_stomach_inflammation | 1.09812692 |
| 65 | MP0003221_abnormal_cardiomyocyte_apopto | 1.09288058 |
| 66 | MP0002332_abnormal_exercise_endurance | 1.08794093 |
| 67 | MP0005666_abnormal_adipose_tissue | 1.05612921 |
| 68 | MP0000604_amyloidosis | 1.02842209 |
| 69 | MP0004233_abnormal_muscle_weight | 1.02189999 |
| 70 | MP0000678_abnormal_parathyroid_gland | 1.01634356 |
| 71 | MP0000015_abnormal_ear_pigmentation | 0.99955216 |
| 72 | MP0005076_abnormal_cell_differentiation | 0.95757666 |
| 73 | MP0000703_abnormal_thymus_morphology | 0.94309252 |
| 74 | MP0001853_heart_inflammation | 0.93366500 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 0.92823034 |
| 76 | MP0006036_abnormal_mitochondrial_physio | 0.91993360 |
| 77 | MP0004130_abnormal_muscle_cell | 0.90812217 |
| 78 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82751245 |
| 79 | MP0000759_abnormal_skeletal_muscle | 0.82693804 |
| 80 | MP0005166_decreased_susceptibility_to | 0.81317033 |
| 81 | MP0008874_decreased_physiological_sensi | 0.78798802 |
| 82 | MP0002106_abnormal_muscle_physiology | 0.78428176 |
| 83 | MP0000609_abnormal_liver_physiology | 0.77243665 |
| 84 | MP0001986_abnormal_taste_sensitivity | 0.76973830 |
| 85 | MP0001663_abnormal_digestive_system | 0.76672338 |
| 86 | MP0000681_abnormal_thyroid_gland | 0.76036336 |
| 87 | MP0004381_abnormal_hair_follicle | 0.75178989 |
| 88 | MP0003329_amyloid_beta_deposits | 0.74930265 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.74041019 |
| 90 | MP0001849_ear_inflammation | 0.73414445 |
| 91 | MP0009763_increased_sensitivity_to | 0.71308059 |
| 92 | MP0009931_abnormal_skin_appearance | 0.71074380 |
| 93 | MP0002019_abnormal_tumor_incidence | 0.70606711 |
| 94 | MP0004858_abnormal_nervous_system | 0.70124880 |
| 95 | MP0005330_cardiomyopathy | 0.69398094 |
| 96 | MP0004087_abnormal_muscle_fiber | 0.69285255 |
| 97 | MP0001851_eye_inflammation | 0.66895292 |
| 98 | MP0005319_abnormal_enzyme/_coenzyme | 0.66298281 |
| 99 | MP0005501_abnormal_skin_physiology | 0.66273977 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.66256700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 4.01848116 |
| 2 | Myopathic facies (HP:0002058) | 3.97511740 |
| 3 | Eczematoid dermatitis (HP:0000976) | 3.92908173 |
| 4 | Abnormality of macrophages (HP:0004311) | 3.49111401 |
| 5 | Petechiae (HP:0000967) | 3.40081560 |
| 6 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.32605550 |
| 7 | Recurrent abscess formation (HP:0002722) | 3.25426841 |
| 8 | Ragged-red muscle fibers (HP:0003200) | 3.24757194 |
| 9 | Hypertensive crisis (HP:0100735) | 3.18537249 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 3.15534668 |
| 11 | Colitis (HP:0002583) | 3.12561061 |
| 12 | Obstructive lung disease (HP:0006536) | 3.11494141 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.11494141 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.10748788 |
| 15 | Rhabdomyolysis (HP:0003201) | 3.07092195 |
| 16 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.05703717 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.05703717 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 3.05703717 |
| 19 | Purpura (HP:0000979) | 3.03241335 |
| 20 | Increased serum ferritin (HP:0003281) | 2.97072386 |
| 21 | Increased cerebral lipofuscin (HP:0011813) | 2.92232113 |
| 22 | Increased IgE level (HP:0003212) | 2.84884102 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 2.83657933 |
| 24 | Reticulocytosis (HP:0001923) | 2.81265719 |
| 25 | Cellulitis (HP:0100658) | 2.78112910 |
| 26 | Prolonged bleeding time (HP:0003010) | 2.71424502 |
| 27 | Abnormal gallbladder physiology (HP:0012438) | 2.68294600 |
| 28 | Cholecystitis (HP:0001082) | 2.68294600 |
| 29 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.66482238 |
| 30 | Loss of speech (HP:0002371) | 2.65747762 |
| 31 | Polycythemia (HP:0001901) | 2.63439454 |
| 32 | Gastrointestinal inflammation (HP:0004386) | 2.61100649 |
| 33 | Myositis (HP:0100614) | 2.59918612 |
| 34 | Myoglobinuria (HP:0002913) | 2.57079263 |
| 35 | Recurrent fungal infections (HP:0002841) | 2.55830231 |
| 36 | Distal lower limb muscle weakness (HP:0009053) | 2.54242793 |
| 37 | Muscle fiber inclusion bodies (HP:0100299) | 2.52984297 |
| 38 | Meningitis (HP:0001287) | 2.49388461 |
| 39 | Abnormality of iron homeostasis (HP:0011031) | 2.46526497 |
| 40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.46121503 |
| 41 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.45212033 |
| 42 | Recurrent viral infections (HP:0004429) | 2.42661057 |
| 43 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.40367770 |
| 44 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.39780181 |
| 45 | Agammaglobulinemia (HP:0004432) | 2.39322929 |
| 46 | Nemaline bodies (HP:0003798) | 2.38809440 |
| 47 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.37826284 |
| 48 | Inflammation of the large intestine (HP:0002037) | 2.36804256 |
| 49 | Distal lower limb amyotrophy (HP:0008944) | 2.35613907 |
| 50 | Stomatitis (HP:0010280) | 2.34881996 |
| 51 | Dysostosis multiplex (HP:0000943) | 2.31004316 |
| 52 | Urticaria (HP:0001025) | 2.30820882 |
| 53 | Orchitis (HP:0100796) | 2.29638549 |
| 54 | Epistaxis (HP:0000421) | 2.26530679 |
| 55 | Gastrointestinal stroma tumor (HP:0100723) | 2.25147773 |
| 56 | Hemorrhage of the eye (HP:0011885) | 2.24400957 |
| 57 | Bulbar palsy (HP:0001283) | 2.24026939 |
| 58 | Asymmetric septal hypertrophy (HP:0001670) | 2.24012709 |
| 59 | Cholelithiasis (HP:0001081) | 2.23097121 |
| 60 | Progressive muscle weakness (HP:0003323) | 2.22347657 |
| 61 | Fatigue (HP:0012378) | 2.21994899 |
| 62 | Increased connective tissue (HP:0009025) | 2.15637894 |
| 63 | Increased IgM level (HP:0003496) | 2.15152472 |
| 64 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.13436930 |
| 65 | Vacuolated lymphocytes (HP:0001922) | 2.13133818 |
| 66 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.09394436 |
| 67 | Recurrent skin infections (HP:0001581) | 2.08007214 |
| 68 | Increased muscle lipid content (HP:0009058) | 2.05865423 |
| 69 | Chest pain (HP:0100749) | 2.05497459 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.03752161 |
| 71 | Neuronal loss in central nervous system (HP:0002529) | 2.03553381 |
| 72 | Gastrointestinal infarctions (HP:0005244) | 2.02887508 |
| 73 | Hyperthyroidism (HP:0000836) | 2.02041921 |
| 74 | EMG: myopathic abnormalities (HP:0003458) | 2.00709169 |
| 75 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.00414802 |
| 76 | Recurrent cutaneous fungal infections (HP:0011370) | 2.00414802 |
| 77 | Abnormality of reticulocytes (HP:0004312) | 2.00009300 |
| 78 | Hyperacusis (HP:0010780) | 1.99115429 |
| 79 | Vasculitis (HP:0002633) | 1.97596656 |
| 80 | Hepatosplenomegaly (HP:0001433) | 1.95563376 |
| 81 | Diaphragmatic weakness (HP:0009113) | 1.95154305 |
| 82 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.93549906 |
| 83 | Progressive external ophthalmoplegia (HP:0000590) | 1.92594220 |
| 84 | Pustule (HP:0200039) | 1.88765974 |
| 85 | Upper motor neuron abnormality (HP:0002127) | 1.87435362 |
| 86 | Thrombocytosis (HP:0001894) | 1.86659488 |
| 87 | Abnormal platelet function (HP:0011869) | 1.84971652 |
| 88 | Impaired platelet aggregation (HP:0003540) | 1.84971652 |
| 89 | Osteomyelitis (HP:0002754) | 1.84930770 |
| 90 | Muscle stiffness (HP:0003552) | 1.84540473 |
| 91 | Increased variability in muscle fiber diameter (HP:0003557) | 1.84251887 |
| 92 | Interstitial pulmonary disease (HP:0006530) | 1.84037069 |
| 93 | Retrobulbar optic neuritis (HP:0100654) | 1.83890121 |
| 94 | Optic neuritis (HP:0100653) | 1.83890121 |
| 95 | Increased intramyocellular lipid droplets (HP:0012240) | 1.83309796 |
| 96 | Gastrointestinal dysmotility (HP:0002579) | 1.83299964 |
| 97 | Gingivitis (HP:0000230) | 1.82697103 |
| 98 | Rimmed vacuoles (HP:0003805) | 1.82651539 |
| 99 | Abnormal gallbladder morphology (HP:0012437) | 1.82507267 |
| 100 | Encephalitis (HP:0002383) | 1.81950126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.93339293 |
| 2 | ERN1 | 3.63741539 |
| 3 | PRPF4B | 3.52308465 |
| 4 | MAP3K11 | 3.23199762 |
| 5 | MAP2K3 | 2.67336495 |
| 6 | TRIB3 | 2.49596202 |
| 7 | SMG1 | 2.49583036 |
| 8 | RIPK4 | 2.44315424 |
| 9 | IRAK3 | 2.42956802 |
| 10 | NME2 | 2.34642348 |
| 11 | ICK | 2.13395858 |
| 12 | TBK1 | 2.02796728 |
| 13 | IRAK4 | 1.94166053 |
| 14 | TAOK2 | 1.93280141 |
| 15 | TESK2 | 1.91549189 |
| 16 | BLK | 1.91053104 |
| 17 | TTN | 1.84371605 |
| 18 | TYK2 | 1.80677121 |
| 19 | MAP3K14 | 1.56535112 |
| 20 | MAP3K13 | 1.52528841 |
| 21 | SIK1 | 1.45525028 |
| 22 | BTK | 1.43642834 |
| 23 | EPHB1 | 1.42917560 |
| 24 | MAP3K1 | 1.42852792 |
| 25 | DYRK1B | 1.40968034 |
| 26 | SIK2 | 1.40611723 |
| 27 | JAK3 | 1.39603718 |
| 28 | ZAP70 | 1.39536623 |
| 29 | EEF2K | 1.35189368 |
| 30 | PIM2 | 1.29068010 |
| 31 | SIK3 | 1.25739773 |
| 32 | MATK | 1.24839837 |
| 33 | TAOK1 | 1.23010869 |
| 34 | OBSCN | 1.21080191 |
| 35 | MAP3K3 | 1.19523338 |
| 36 | FGR | 1.07934129 |
| 37 | CDK19 | 1.06361350 |
| 38 | BMX | 1.04774166 |
| 39 | SYK | 1.03714359 |
| 40 | PRKD2 | 1.02339047 |
| 41 | TNK2 | 1.01312281 |
| 42 | IKBKB | 1.01144379 |
| 43 | MARK2 | 0.99626760 |
| 44 | CSK | 0.99383586 |
| 45 | MAPK12 | 0.96660320 |
| 46 | GRK6 | 0.90609551 |
| 47 | KSR2 | 0.90602060 |
| 48 | MAPK11 | 0.87477497 |
| 49 | HCK | 0.84975974 |
| 50 | CSF1R | 0.84909222 |
| 51 | MAP2K6 | 0.83449534 |
| 52 | MAP3K6 | 0.83110055 |
| 53 | PDPK1 | 0.79808790 |
| 54 | MAP3K10 | 0.78515212 |
| 55 | RIPK1 | 0.77704949 |
| 56 | ARAF | 0.77244413 |
| 57 | FGFR4 | 0.75922562 |
| 58 | RPS6KC1 | 0.75653036 |
| 59 | RPS6KL1 | 0.75653036 |
| 60 | MARK3 | 0.75127333 |
| 61 | CDK4 | 0.74678090 |
| 62 | HIPK2 | 0.71627763 |
| 63 | IKBKE | 0.71399181 |
| 64 | JAK2 | 0.70738909 |
| 65 | PKN2 | 0.70535940 |
| 66 | LYN | 0.69308274 |
| 67 | PTK6 | 0.68653208 |
| 68 | MAP2K4 | 0.68362761 |
| 69 | CDC42BPA | 0.65996211 |
| 70 | MAP3K7 | 0.65979668 |
| 71 | LRRK2 | 0.65613628 |
| 72 | BCKDK | 0.65165204 |
| 73 | IRAK2 | 0.64995224 |
| 74 | FES | 0.60980174 |
| 75 | CDK6 | 0.58288118 |
| 76 | RPS6KA2 | 0.57303838 |
| 77 | RPS6KA6 | 0.56749308 |
| 78 | MAP2K2 | 0.56000585 |
| 79 | PDK1 | 0.53862251 |
| 80 | MAPKAPK3 | 0.50784245 |
| 81 | MAP3K5 | 0.48985304 |
| 82 | LCK | 0.47413297 |
| 83 | PIM1 | 0.47412323 |
| 84 | SCYL2 | 0.44169444 |
| 85 | MTOR | 0.43408082 |
| 86 | MAP3K8 | 0.42838740 |
| 87 | TESK1 | 0.41898658 |
| 88 | DDR2 | 0.40315297 |
| 89 | BRAF | 0.40083160 |
| 90 | DYRK3 | 0.40031853 |
| 91 | TAOK3 | 0.38635724 |
| 92 | MAPK4 | 0.37724270 |
| 93 | TYRO3 | 0.37556501 |
| 94 | RPS6KA1 | 0.37527476 |
| 95 | CDK12 | 0.36068276 |
| 96 | PRKD1 | 0.33977590 |
| 97 | PAK4 | 0.32963723 |
| 98 | CHUK | 0.30346138 |
| 99 | KIT | 0.30205224 |
| 100 | AKT2 | 0.29999671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.16641164 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.62419641 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.57760361 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.54080889 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.38183403 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.30606520 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.27819813 |
| 8 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.21658239 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.20404471 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.18114091 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.11381104 |
| 12 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.04628584 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.97275055 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.95317382 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.86752021 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.85979539 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.71795594 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.69177809 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.65409558 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.61568239 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.60419488 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.54571207 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53728445 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.52861334 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46944166 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.46785334 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43604580 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.40503938 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39991092 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.34661660 |
| 31 | Galactose metabolism_Homo sapiens_hsa00052 | 1.29331963 |
| 32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.28175028 |
| 33 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.26365800 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.15016238 |
| 35 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.14747064 |
| 36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14744293 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.13908693 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.13148551 |
| 39 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.12639672 |
| 40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.12529868 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12455143 |
| 42 | Bladder cancer_Homo sapiens_hsa05219 | 1.10787221 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09896051 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09068562 |
| 45 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.06665113 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.05708263 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.05693863 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 1.03611067 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.03463726 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03268918 |
| 51 | Malaria_Homo sapiens_hsa05144 | 1.02134058 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 1.01958374 |
| 53 | Apoptosis_Homo sapiens_hsa04210 | 1.01203297 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 1.00501806 |
| 55 | Measles_Homo sapiens_hsa05162 | 0.99436724 |
| 56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94063767 |
| 57 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93702479 |
| 58 | Legionellosis_Homo sapiens_hsa05134 | 0.93518279 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.92054426 |
| 60 | Base excision repair_Homo sapiens_hsa03410 | 0.90861122 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89316528 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88432170 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87840959 |
| 64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82888070 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.82732024 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.80988893 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79537705 |
| 68 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77413848 |
| 69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76474518 |
| 70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73715576 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 0.72472322 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69638953 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68644097 |
| 74 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65540228 |
| 75 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61447683 |
| 76 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.60503375 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59324918 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.56695041 |
| 79 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.56350746 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55873787 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55006402 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.54632822 |
| 83 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54397263 |
| 84 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53169273 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52460456 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51974608 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51358237 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50646002 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50154887 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47172044 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43963624 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42855313 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42045037 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37320940 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37159265 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36353871 |
| 97 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.34924091 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33794062 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33502145 |
| 100 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33372039 |

